News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
renalyse-gensisbiomed-ndp-asebio
Renalyse has successfully closed an investment round of 1 M€ in public and private capital
Access to innovation · Financing
The operation was led by the Mind the Gap program from Botín Foundation, with participation from…
Partners - GENESIS Biomed
Wendy_Morales_ProductLife_Group
#NewMemberAseBio | "AseBio is an opportunity to help organizations in the sector understand regulation, the changes that occur, and keep their products safe in the market"
Access to innovation
Meet ProductLife Group, our new partner. We spoke with Wendy Morales, business…
Partners - ProductLife Group
Equipo_ADMIT
ADmit therapeutics closes a €5.4 million funding round led by Clave Capital, through its Clave Innohealth f.c.r. fund
Financing
The European Innovation Council (EIC) Fund and the Alzheimer's Drug Discovery Foundation (ADDF)…
Partners - ADmit Therapeutics
Ribonuclease H processing the hybrid DNA RNA helix
Simulation tools drive the new generation of therapies based on gene silencing
Healthcare
Researchers at Nostrum Biodiscovery, with the collaboration of other companies, have laid the…
Partners - Nostrum Biodiscovery
Profesional_sanitario_AseBio
BCN HEALTH publishes a study evaluating the incidence, mortality and medical costs associated to melanoma in Spain
Healthcare
BCN HEALTH conducted a retrospective study based on the records of patients diagnosed with a…
Partners - BCN Health
Ackermann
"Silence kills"
Healthcare
Studies indicate that more than 60 percent of medication errors are caused by mistakes in…
Partners - Ackermann International
Laboratorio_biotecnología_AseBio
ORYZON receives two grants to further explore the role of epigenetic targets in the treatment of neuronal pathologies
Healthcare
Two collaborative projects with public research centers with a global budget of 2.3 million euros.
Partners - Oryzon Genomics
Génesis_BIOSPAIN
"BIOSPAIN allows the creation of a sense of belonging to a leading sector that is already one of the engines of growth"
BioSpain
BIOSPAIN, the largest biotechnology event organised by a national bioindustry association in Europe…
Partners - GENESIS Biomed
oryzon-genomics-asebio-ndp-biotech
ORYZON to provide corporate progress updates at several events in October
Corporate
Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop…
Partners - Oryzon Genomics